Drugs currently in the clinical pipeline are mostly the modifications of existing classes of antibiotics and are only short-term solutions
GN Bureau | September 20, 2017
There is going to be a huge lack of new antibiotics in coming future. A report by the World Health Organisation (WHO) has revealed that there is “a serious lack of new antibiotics under development to combat the growing threat of antimicrobial resistance.”
The report called Antibacterial agents in clinical development – an analysis of the antibacterial clinical development pipeline, including tuberculosis was released on Wednesday.
According to the report, drugs currently in the clinical pipeline are mostly the modifications of existing classes of antibiotics and are only short-term solutions. The report found very few potential treatment options for those antibiotic-resistant infections identified by WHO as posing the greatest threat to health, including drug-resistant tuberculosis which kills around 250 000 people each year.
Director general, WHO, Dr Tedros Adhanom Ghebreyesus has termed antimicrobial resistance as a global health emergency. "There is an urgent need for more investment in research and development for antibiotic-resistant infections including TB, otherwise we will be forced back to a time when people feared common infections and risked their lives from minor surgery,” he said in an official statement.
WHO has identified 12 classes of priority pathogens, some of them causing common infections such as pneumonia or urinary tract infections, that are increasingly resistant to existing antibiotics and urgently in need of new treatments.
“There is a serious lack of treatment options for multidrug- and extensively drug-resistant M. tuberculosis and gram-negative pathogens, including Acinetobacter and Enterobacteriaceae (such as Klebsiella and E.coli) which can cause severe and often deadly infections that pose a particular threat in hospitals and nursing homes,” the report said.
"Pharmaceutical companies and researchers must urgently focus on new antibiotics against certain types of extremely serious infections that can kill patients in a matter of days because we have no line of defence," says Dr Suzanne Hill, Director of the Department of Essential Medicines at WHO.
The conundrum in Maharashtra is moving towards resolution, as the Shiv Sena has secured the support of the ideological opponents, the Congress and the NCP, to form the government, after the BJP, the party with the most seats, failed to muster the numbers. NCP chief Sharad Pawar has taken the
Gotabaya Rajapaksa, the new president of Sri Lanka, won the November elections that were held amid continued polarization in the island nation. As defence secretary, he had led the government’s decisive fight against the LTTE rebels in 2009, in which most of the guerrilla leaders were killed. Thus en
Sahitya Akademi, the autonomous organization under the ministry of culture, has been silently promoting Indian literature abroad through a host of activities, including promotion of translations. The Akademi has helped translate much-talked about Bangla novel ‘Herbert’ by Nabarun
Once a guest hands over the car keys to the valet, the vehicle is under the hotel’s responsibility, and it will have to compensate any damage to it, the supreme court has ruled. In a judgment under the contract law, a bench of justices Mohan M Shantanagoudar and Ajay Rastogi has upheld
Amid oversupply, slackening demand and financial troubles, many builders have not been able to deliver homes to buyers, leaving the latter in the lurch. The buyers in turn have taken recourse to filing cases against builders: a total of 1,821 cases under the Insolvency and Bankruptcy Code (IBC) 2016 were p
The beginning of its historic 250th session gave the upper house of parliament an opportunity to take stock of its past and its future, the challenges ahead and the ways to meet them. The house on Monday took up a discussion on ‘The Role of Rajya Sabha in Indian Polity and the Way Forw